Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum Hepatitis Incidence with TDF Withdrawal
NCT03214302Unknown
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: The incidence rate of hepatitis flare after drug withdrawal in maternal postpartum. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03214302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214302.